A new trial in Italy will test two self-help programs for adult migrants who are dealing with elevated psychological distress. The programs are Self-Help Plus, which is delivered in person, and Doing What Matters in Times of Stress, which is delivered online. Each includes an extra booster session. A third group will receive a psychological placebo without active ingredients.
The trial plans to include 237 people. The main measure is depressive and anxiety symptoms at 3 months after randomization, using the Patient Health Questionnaire-Anxiety and Depression Scale. The trial will also look at functioning, wellbeing, quality of life, self-stigma, and the cost of care.
This is a study protocol, which means it describes the plan for a trial. No results are available yet. The protocol does not report safety information, funding, or conflicts of interest.
Readers should treat this as an early step, not evidence that these programs work. The trial has not yet produced findings, so it cannot show whether the programs help or are safe. Results will be needed before anyone can draw conclusions.
Common questions
What is this study testing?
It is testing two self-help programs for adult migrants in Italy with elevated psychological distress. One is Self-Help Plus, given in person. The other is Doing What Matters in Times of Stress, given online. Both include an extra booster session. A third group gets a psychological placebo without active ingredients.
Are there any results yet?
No. This is a study protocol, which describes the plan for a trial. The trial has not reported results, so there is no evidence yet on whether the programs help or are safe. Findings will come later.
Who is in the study?
The trial plans to include 237 adult migrants resettled in Italy who have elevated psychological distress. The main measure is depressive and anxiety symptoms at 3 months after randomization. The trial also plans to look at functioning, wellbeing, quality of life, self-stigma, and cost of care.
What are the side effects?
The protocol does not report adverse events, serious adverse events, discontinuations, or tolerability. Because no results are available, there is no information yet on side effects. Anyone with concerns about mental health treatment should talk with a doctor.